JPMorgan analyst Tycho Peterson downgraded Accuray (ARAY) to Neutral citing a "sluggish" end market and the company's ongoing operational challenges. Accuray has not demonstrated consistent order growth or the ability to drive market share, Peterson tells investors in a research note. He lowered his price target for the shares to $6 from $8. The analyst's top picks in the Life Sciences space for 2017 are Agilent (A) and Thermo Fisher (TMO). Peterson this morning also downgraded Bruker (BRKR) to Underweight,
Deutsche Bank raised the firm's price target on Thermo Fisher to $610 from $600 and keeps a Buy rating on the shares post the Q1 report. The analyst says a solid operational performance drove a strong start to 2024.
Barclays analyst Luke Sergott raised the firm's price target on Thermo Fisher to $615 from $590 and keeps an Equal Weight rating on the shares. The company reported a beat across the board, says the analyst, who sees the business stabilizing.
Check out this morning's top movers from around Wall Street, compiled by The Fly. UP AFTER EARNINGS... To see the rest of the story go to thefly.com. See Story Here